Wei AH, Döhner H, Pocock C, Montesinos P, Afanasyev B, Dombret H, et al. Oral azacitidine maintenance therapy for acute myeloid leukemia in first remission. New Engl J Med 2020;383(26):2526-2537.PMID: 33369355
DiNardo CD, Jonas BA, Pullarkat V, Thirman MJ, Garcia JS, Wei AH, et al. Azacitidine and venetoclax in previously untreated acute myeloid leukemia. New Engl J Med 2020;383(7):617-629.PMID: 32786187
Stone RM, Mandrekar SJ, Sanford BL, Laumann K, Geyer S, Bloomfield CD,….., Wei A et al. Midostaurin plus chemotherapy for acute myeloid leukemia with a FLT3 Mutation. New Engl J Med 2017;377(5):454-464.PMID: 28644114
Kantarjian H, Stein A, Gökbuget N, Fielding AK, Schuh AC, Ribera J-M, Wei A et al. Blinatumomab versus chemotherapy for advanced acute lymphoblastic leukemia. New Engl J Med 2017;376(9):836-847.PMID: 28249141
Wei AH, Montesinos P, Ivanov V, DiNardo CD, Novak J, Laribi K, et al. Venetoclax plus LDAC for newly diagnosed AML ineligible for intensive chemotherapy: a phase 3 randomized placebo-controlled trial. Blood 2020;135(24):2137-2145.PMID: 32219442
Wei AH, Strickland SA, Hou J-, Fiedler W, Lin TL, Walter RB, et al. Venetoclax combined with low-dose cytarabine for previously untreated patients with acute myeloid leukemia: Results from a phase Ib/II study. J Clin Oncol 2019;37(15):1277-1284.PMID: 30892988
Moujalled DM, Brown FC, Chua CC, Dengler MA, ….., Wei AH. Acquired mutations in BAX confer resistance to BH3-mimetic therapy in acute myeloid leukemia. Blood 2022 Oct 11: blood.2022016090.PMID: 36219880
Chua CC, Roberts AW, Reynolds J, Fong CY, Ting SB, Salmon JM, ….., Wei AH. Chemotherapy and Venetoclax in Elderly Acute Myeloid Leukemia Trial (CAVEAT): A Phase Ib Dose-Escalation Study of Venetoclax Combined with Modified Intensive Chemotherapy. J Clin Oncol 2020;38(30):3506-3517.PMID: 32687450
Moujalled DM, Pomilio G, Ghiurau C, Ivey A, Salmon J, Rijal S, …., Wei AH. Combining BH3-mimetics to target both BCL-2 and MCL1 has potent activity in pre-clinical models of acute myeloid leukemia. Leukemia 2019;33(4):905-917.PMID: 30214012
Döhner H, Wei AH, Appelbaum FR, Craddock C, DiNardo CD, Dombret H, et al. Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN. Blood 2022;140(12):1345-1377.PMID: 35797463
Döhner H, Estey E, Grimwade D, Amadori S, Appelbaum FR, Büchner T, ….., Wei AH, Löwenberg B, Bloomfield CD. Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel. Blood 2017;129(4):424-447.PMID: 27895058
